Research & Innovation

Latest edition of research

Cancer research

Bayer’s successful acquisition of Schering gave a tremendous boost to Bayer HealthCare’s research capabilities in the battle against cancer. The title story in the latest edition of research features reports on promising substances that are currently undergoing clinical testing, and takes a look at the new approaches being taken by the Bayer Schering Pharma Division. » more

Audio Podcast
Innovative protection against thrombosis
Rivaroxaban is a novel substance currently in development for the prevention and treatment of thrombosis. It could revolutionize clinical practice.

6:35 min.

Video Podcast
Understanding multiple sclerosis
The autoimmune disorder MS remains incurable. Active ingredients manufactured with biotechnological means can however delay its progression .

6:27 min.

How Prof. Dr. Carell discovered the secrets of DNA repair

Video Podcast
How Prof. Carell discovered the secrets of DNA repair
Repairs to defective DNA take one billionth of a second. Thomas Carell, winner of the Otto Bayer Prize 2008, was the first to capture them on film.

5:32 min.

News

May 7, 2008

IFAT 2008
Wastewater treatment process "made by Bayer"
Bayer Technology Services presents proven environmental protection technologies at the leading international trade fair for the environmental sector. » more

News Overview